Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue

Human Pathology

Volumn 27, Issue 7, 1996, Pages 688-694

  Glynne Jones, E ^a   Goddard, L ^a   Harper, M E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

epidermal growth factor receptor; in situ hybridization; proliferative index; prostate adenocarcinoma; transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 0029984880     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90399-8     Document Type: Article

References (32)

1. Prigent SA, Lemione NR: The type 1 (EGF-R) family of growth factors and their ligands. Prog Growth Factor Res 4:1-24, 1992
2. Thompson DM, Gill GNP: The EGF receptor: Structure regulation and potential role in malignancy. Cancer Surv 4:767-788, 1985
3. Nicholson S, Halcrow P, Farndon JR, et al: Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet 1:182-185, 1989
4. Gullick WJ: Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47:87-98, 1991
5. Rosenthal A, Lindquist PB, Bringman TS, et al: Expression in rat fibroblasts of a human transforming growth factor cDNA results in transformation. Cell 46:301-309, 1986
6. Sandgren EP, Luetteke NC, Palmiter PD, et al: Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121-1135, 1990
7. Jhappan C, Stahle C, Harkins RN, et al: TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146, 1990
8. Matsui Y, Halter SA, Holt JT, et al: Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 61:1147-1155, 1990
9. Taylor TB, Ramsdell JS: Transforming growth factor-α and its receptor are expressed in the epithelium of the rat prostate gland. Endocrinology 133:1306-1311, 1993
10. Wilding G, Valverius E, Knabbe C, et al: Role of transforming growth factor-α in human prostate cancer cell growth. Prostate 15:1-12, 1989
11. Mostofi FK, Sesterheln I, Sobin LH: Histological typing of prostatic tumours (International Histological Classification of Tumours, No. 22). Geneva, Switzerland, World Health Organization, 1980
12. Glynne-Jones E, Harper ME, Goddard L, et al: Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate 25:210-218, 1994
13. Montone KT, Tomaszewski JE: In situ hybridization for epidermal growth factor receptor (EGF-R) external domain transcripts in prostatic adenocarcinoma. J Clin Lab Anal 7:188-195, 1993
14. Harper ME, Goddard L, Glynne-Jones E, et al: Epidermal growth factor receptor expression by northern analysis and immunohistochemistry in benign and malignant prostatic tumours. Eur J Cancer 31A:1492-1497, 1995
15. Harper ME, Goddard L, Glynne-Jones E, et al: An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors. Prostate 23:9-23, 1993
16. Hepburn J, Glynne-Jones E, Goddard L, et al: Cell proliferation in prostatic carcinoma: Comparative analysis of Ki-67, MIB-1 and PCNA. Histochem J 27:196-203, 1995
17. Eaton CL, Davies P, Phillips ME: Growth factor involvement and oncogene expression in prostatic tumors. J Steroid Biochem 30:341-345, 1988
18. Fiorelli G, De Bellis A, Pioli P, et al: Growth factors in the human prostate. J Steroid Biochem Mol Biol 40:199-205, 1991
19. Ibrahim GK, Kerns BM, MacDonald JA, et al: Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostate tissues. J Urol 149:170-173, 1993
20. Maddy SQ, Chisholm GD, Busuttil A, et al: Epidermal growth factor receptors in human prostate cancer: Correlations with histological differentiation of the tumor. Br J Cancer 60:41-44, 1989
21. Mellon K, Thompson S, Charlton RG, et al: p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol 147:496-499, 1992
22. Morris GL, Dodd JG: Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143:1272-1274, 1990
23. Turken LN, Sakr WA, Wykes SM, et al: Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate 25:199-205, 1994
24. Myers RB, Kudlow JE, Grizzle WE: Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Mod Pathol 6:733-737, 1993
25. Ching KZ, Ramsey E, Pettigrew N, et al: Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126:151-158, 1993
26. Yang Y, Chisholm GD, Habib FK: Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: Their relationships with tissue androgen levels. Br J Cancer 67:152-155, 1993
27. Maygarden SG, Strom S, Ware JL: Localisation of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116:269-273, 1992
28. Hofer DR, Sherwood ER, Bromberg WD, et al: Autonomous growth of androgen-independent human prostatic cell lines: Role of transforming growth factor a. Cancer Res 51:2780-2785, 1991
29. Harper ME, Goddard L, Wilson DW, et al: Pathological and clinical associations of Ki-67 defined growth fractions in human pros-tatic carcinoma. Prostate 21:75-84, 1992
30. Nicholson RI, McClelland RA, Finlay P, et al: Relationship between EGF-R, c-erbB2 protein expression and Ki-67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 29A:1018-1023, 1993
31. Nicholson RI, McClelland RA, Gee JMW, et al: Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy. Breast Cancer Res Treat 29:117-125, 1994
32. Nicholson RI, McClelland RA, Gee JMW, et al: Transforming growth factor alpha and endocrine sensitivity in breast cancer. Cancer Res 54:1684-1689, 1994